When you inject semaglutide, it mimics the action of naturally occurring GLP-1, a hormone released by your intestines after eating
Results for continuous variables are presented as mean and standard deviation (SD)
"With Lilly able to adequately supply current and future demand for tirzepatide, we believe it could continue to grow market share in incretin products as manufacturing continues to expand," BMO Capital Markets senior research analyst Evan Seigerman wrote in a note to clients
GLP-1 Medications and Gallbladder Risk in Patients Who Still Have One For patients with an intact gallbladder, some observational data suggests that rapid weight loss from GLP-1 therapy may increase the risk of gallstone formation, particularly during the initial weeks of treatment
Some compounding pharmacies offer it anyway, operating under the rationale that: It's prescribed by a licensed provider for a specific patient (503A pathway) The compound is not explicitly prohibited (no FDA warning letter or enforcement action yet) State pharmacy boards have not prohibited it What could change: If the FDA decides compounding of investigational drugs violates federal law, they could issue warning letters to pharmacies offering compounded retatrutide
CJC-1295 and ipamorelin both push the pituitary gland to release more of your own growth hormone (GH)